← Eichor
Condition: Healthy Male Participants Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Healthy Male Participants

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

OCTA in Cardiovascular Disease and Healthy Controls
NA · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT07359664Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia
Phase 1/Phase 2 · 4 location(s) · Absci Pty Ltd. · NCT07317544A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Disease
Phase 1 · 28 location(s) · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · NCT07115745A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and Tolerability of Bmab3000 and Hercep
Phase 1 · 1 location(s) · Biocon Biologics UK PLC · NCT07299955A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants a
Phase 1 · 5 location(s) · AstraZeneca · NCT07024823A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Japanese Healthy People and Japanese People With
Phase 1 · 3 location(s) · Boehringer Ingelheim · NCT07693231A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fas
Phase 1 · 1 location(s) · Berlin-Chemie AG Menarini Group · NCT07201584A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy Participants
Phase 1 · 1 location(s) · Jazz Pharmaceuticals · NCT07377539Drug-Interaction Assessment of GSK3772701 in Healthy Male and Female Participants Aged 18 to 55 Years
Phase 1 · 1 location(s) · GlaxoSmithKline · NCT07670377A Study to Test How Well Different Doses of BI 3804379 Are Tolerated by Healthy People and Patients With Metabolic Dysfu
Phase 1 · 1 location(s) · Boehringer Ingelheim · NCT06575400A Study in Healthy Men to Test How BI 1815368 is Processed in the Body
Phase 1 · 1 location(s) · Boehringer Ingelheim · NCT07693218Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019
Phase 1 · 1 location(s) · Grünenthal GmbH · NCT07479745A Study of JPH034 in Healthy Adult Participants
Phase 1 · 1 location(s) · J-Pharma Co., Ltd. · NCT07534657Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepati
Phase 1 · 2 location(s) · Atea Pharmaceuticals, Inc. · NCT06911320A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated
Phase 1 · 1 location(s) · Boehringer Ingelheim · NCT06745297A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
Phase 1/Phase 2 · 5 location(s) · Ingenia Therapeutics INC · NCT07231679Single-ascending Dose Study of HEC-151 Injection
Phase 1 · 2 location(s) · Sunshine Lake Pharma Co., Ltd. · NCT07376200A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy.
Phase 1/Phase 2 · 1 location(s) · Beijing Mabworks Biotech Co., Ltd. · NCT07375758A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years
Phase 1 · 1 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT07413666A Study of ORN252 in Healthy Participants
Phase 1 · 1 location(s) · Orna Therapeutics, Inc. · NCT07439796A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Hea
Phase 1 · 1 location(s) · Boehringer Ingelheim · NCT07656792A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Dis
Phase 1/Phase 2 · 43 location(s) · AstraZeneca · NCT06749457A Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of [14C]-MRM-3379
Phase 1 · 1 location(s) · Mirum Pharmaceuticals, Inc. · NCT07712718A Study to Evaluate the Safety, Tolerability and PK of SK-08
Phase 1 · 1 location(s) · Consun Pharmaceutical Group · NCT07021157A Study to Evaluate the Effect of Food on the Bioavailability of AJ201, and Safety, Tolerability, and Pharmacokinetics o
Phase 1 · 1 location(s) · AnnJi Pharmaceutical Co., Ltd. · NCT07549919A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients Wit
Phase 1 · 16 location(s) · eleva GmbH · NCT07483827A Study to Evaluate the Safety of Increasing Doses of DF5112 in Healthy Adults
Phase 1 · 1 location(s) · Dragonfly Therapeutics · NCT07232121Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing
Phase 1 · 3 location(s) · Novartis Pharmaceuticals · NCT07626281A Methodological Study to Learn More About Kidney Function in Healthy People and in People With Reduced Kidney Function
NA · 1 location(s) · Bayer · NCT07368712Direct to Patient Minimal Risk Biospecimen and Data Collection Research
Phase N/A · 1 location(s) · Joined Bio · NCT07128966
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.